S8886851
AtorvastatinRelatedCompoundA , UnitedStatesPharmacopeia(USP)ReferenceStandard , 433289-83-9
Synonym(s):
(βR,δR)-β,δ-Dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt
CAS NO.:433289-83-9
Empirical Formula: C33H35CaN2O5+
Molecular Weight: 579.719
MDL number: MFCD11977955
| Pack Size | Price | Stock | Quantity |
| 20MG | RMB10501.34 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 150℃ (decomposition) |
| storage temp. | 2-8°C |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| Stability: | Hygroscopic |
| InChIKey | HBFCHKRJRYFUBH-QXFSHCJSNA-M |
| SMILES | c1(-c2ccccc2)c(C(=O)Nc2ccccc2)c(C(C)C)[n](CC[C@@H](O)C[C@@H](O)CC([O-])=O)c1-c1ccccc1.[Ca+2] |&1:24,27,r| |
Description and Uses
Desfluoro Atorvastatin is an impurity in the synthesis of Atorvastatin (A791750), a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| HS Code | 2933997500 |







